ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 090,99
0,00%
Dow Jones
43 461,21
0,08%
DAX
22 421,36
0,00%
Brent Oil
74,47
-0,02%
Bitcoin
89 644,51
-1,97%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. ALX Oncology Holdings Inc (ALXO) Cours

ALX Oncology Holdings Inc

ALX Oncology Holdings Inc (ALXO)

NASDAQ
1,07
0,00
(0,00%)
Fermé 25 Février 10:00PM
Retardé de 15 minutes
0,00
0,00
(0,00%)
Après les heures de négociation: -
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
1,07
Prix Achat
1,08
Prix Vente
1,12
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,9626 Plage de 52 semaines 17,825
Cap du marché
56,435M
Clôture Veille
1,07
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 005 872
Actions en circulation
52 743 104
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,35
Bénéfice par action (BPA)
-3,05
Chiffre d'affairess
-
Bénéfice net
-160,81M

À propos de ALX Oncology Holdings Inc

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer... ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.alxoncology.com
Siège social
Wilmington, Delaware, USA
Fondé
-
ALX Oncology Holdings Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ALXO. Le dernier cours de clôture d'ALX Oncology était de US$1,07. Au cours de la dernière année, les actions de ALX Oncology ont été négociées dans une fourchette de prix de US$ 0,9626 à US$ 17,825.

ALX Oncology compte actuellement 52 743 104 actions en circulation. La capitalisation boursière d'ALX Oncology est de US$56,44 million. ALX Oncology a un ratio cours/bénéfice (ratio PE) de -0.35.

ALXO Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Février 2025
ALXO (0,00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Février 2025
ALXO (0,00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
24 Janvier 2025
ALXO (0,00%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
24 Janvier 2025
ALXO (0,00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
24 Janvier 2025
ALXO (0,00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
24 Janvier 2025
ALXO (0,00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
24 Janvier 2025
ALXO (0,00%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.05-4.464285714291.121.221.043931581.14547686CS
4-0.47-30.51948051951.541.540.96266967551.2444346CS
12-0.605-36.11940298511.6752.050.962610058721.55949115CS
26-1.32-55.2301255232.392.5850.96268216551.61079642CS
52-14.69-93.210659898515.7617.8250.96268980995.07422559CS
156-15.44-93.519079345916.5120.40.96265755077.13153295CS
260-29.37-96.484888304930.44117.450.962647064415.79777636CS

ALXO - Frequently Asked Questions (FAQ)

What is the current ALX Oncology share price?
The current share price of ALX Oncology is US$ 1,07
How many ALX Oncology shares are in issue?
ALX Oncology has 52 743 104 shares in issue
What is the market cap of ALX Oncology?
The market capitalisation of ALX Oncology is USD 56,44M
What is the 1 year trading range for ALX Oncology share price?
ALX Oncology has traded in the range of US$ 0,9626 to US$ 17,825 during the past year
What is the PE ratio of ALX Oncology?
The price to earnings ratio of ALX Oncology is -0,35
What is the reporting currency for ALX Oncology?
ALX Oncology reports financial results in USD
What is the latest annual profit for ALX Oncology?
The latest annual profit of ALX Oncology is USD -160,81M
What is the registered address of ALX Oncology?
The registered address for ALX Oncology is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the ALX Oncology website address?
The website address for ALX Oncology is www.alxoncology.com
Which industry sector does ALX Oncology operate in?
ALX Oncology operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SXTCChina SXT Pharmaceuticals Inc
US$ 0,84
(145,54%)
29,14M
STECSantech Holdings Limited
US$ 1,575
(142,20%)
121,33M
YYAIConnexa Sports Technologies Inc
US$ 1,245
(94,50%)
150,24M
ATPCAgape ATP Corporation
US$ 1,60
(70,94%)
75,86M
PEPGPepGen Inc
US$ 2,2868
(66,92%)
108,17M
THTarget Hospitality Corporation
US$ 5,10
(-45,51%)
12,97M
ICCTiCoreConnect Inc
US$ 1,33
(-35,12%)
289,5k
STAIScanTech AI Systems Inc
US$ 2,1401
(-34,95%)
5,07M
AGHAureus Greenway Holdings Inc
US$ 3,59
(-33,40%)
982,27k
BOXLBoxlight Corporation
US$ 2,12
(-31,61%)
509,58k
NVDANVIDIA Corporation
US$ 130,28
(-3,09%)
246,72M
PLTRPalantir Technologies Inc
US$ 90,68
(-10,53%)
180,51M
YYAIConnexa Sports Technologies Inc
US$ 1,245
(94,50%)
150,24M
STECSantech Holdings Limited
US$ 1,575
(142,20%)
121,33M
ADTXAditxt Inc
US$ 0,0867
(-5,25%)
118,71M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ALXO
ALX Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces